Archives acetylon-pharmaceuticals

by in
Entry Author Date Location
Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech 04/29/15 New York
East Coast Biotech Roundup: Juno, Editas, Celgene, & More 12/06/13 Boston
Celgene Plunks Down $177M Upfront for OncoMed’s Stem Cell Drugs 12/03/13 San Francisco
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
Acetylon Pharmaceuticals Obtains $100,000,000 New Funding Round 07/30/13 Boston
Celgene Nabs Option to Buy Acetylon for More Than $1.7B 07/29/13 Boston
Synchroneuron, Radius, Acetylon, & More Boston Life Sciences News 02/10/12 Boston
Acetylon Pharmaceuticals Secures $15,000,000 New Round 02/09/12 Boston
RXi Splits Up, Zeo Launches Mobile Sleep-Tracking App, Karuna Licenses Schizophrenia Compounds, & More Boston-Area Life Sciences News 09/30/11 Boston
Backed by Eclectic Financiers, Acetylon Begins Trials of Cancer Drug 09/27/11 Boston
Zynga Files For IPO, Brightcove Inks Boston Lease, Lotus Adds $26M, & More Boston-Area Deals News 07/06/11 Boston
Acetylon Adds $27M, Third Rock Leads Lotus Round, InfraReDx Gets $24M, & More Boston-Area Life Sciences News 07/01/11 Boston
Acetylon, Backed by Patriots Owner Bob Kraft, Snags $27M to Develop New Cancer Drugs 06/29/11 Boston
Acetylon Pharmaceuticals Receives $14,600,000 Series B Round 06/29/11 Boston
GSK Backs SpringLeaf, Prexa Nabs $7M from Advent & Shire, Acetylon Gets $5M Partnership, & More Boston-Area Life Sciences News 05/13/11 Boston
Acetylon Nabs $4.9M for Myeloma Drug 05/11/11 Boston
Constant Contact Buys Bantam Live, Forest Pays $1.2B for Clinical Data, Paydiant Scores $7.6M, & More Boston-Area Deals News 02/23/11 Boston
Acetylon Pharma Raises $12.4M 02/22/11 Boston
Acetylon Pharmaceuticals Secures $12,400,000 Series B Financing Round 02/22/11 Boston
Constellation Pharma Hires New CEO, Collects Last $17M of its Series A Financing 08/13/09 Boston
Biogen Idec Faces Suit From Partner Elan, Genzyme Wins European Approval for Stem-Cell Boosting Drug, Alnylam Teams with Tekmira, & More Boston-Area Life Sciences News 08/12/09 Boston
Biotech Startup Acetylon Pharma Catches $7.25M in A Round from Backers Such As New England Patriots Owner 08/07/09 Boston
Page 1 of 1